MedPage Today2h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Healio2h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
FDA Approves First Rapid-Acting Insulin Biosimilar Product For Treatment Of Diabetes
Agency Continues Efforts to Increase Access to Insulin Treatment Options SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S.
Type 1 diabetes: Hybrid closed-loop and open-loop systems therapies compared
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Healthline12h
NSYNC’s Lance Bass Says Managing Type 1.5 Diabetes Is a 'Full-Time Job'
NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...
Over half of Type 1 diabetes patients feel their daily lives are restricted, survey shows
A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...
New gene switch activates with simple skin patch and could help treat diabetes
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
Does Medicare Cover Ozempic?
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Minnesota Daily3d
Insulin costs capped at $35 per month in Minnesota
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...